We describe three patients with abdominal aortic aneurysm (AAA) and renal artery stenosis (RAS). These patients were treated by placement of an aortic endograft and angioplasty or stenting of the renal artery. After the procedure renal function improved or remained stable in two patients and deteriorated slightly in one. Blood pressure was reduced in one hypertensive
Introduction
Atherosclerotic renovascular disease is an important cause of hypertension and renal dysfunction. The incidence increases with age and usually coexists with atherosclerotic disease elsewhere. Several studies have evaluated the prevalence of renal artery stenosis (RAS) in patients undergoing angiography for a variety of extrarenal vascular problems including abdominal aortic aneurysms, coronary artery disease, peripheral vascular disease and aortoocclusive disease. [1] [2] [3] We describe three patients with abdominal aortic aneurysm (AAA) and RAS who were treated by placement of an aortic endograft and renal artery angioplasty (with or without stent). Figure 1 (angiography and CT) shows the placement of stent and aortic endograft.
with renal artery stenosis of about 80%, blood pressure 135/85 mm Hg and serum creatinine 3.1 mg/dl. The left kidney had previously been removed for nephrolithiasis.
This patient was simultaneously treated by placement of an aortic endograft with a proximal uncovered suprarenal stent and by renal artery angioplasty. Eight months after the procedure he is still well and his blood pressure was 140/80 mm Hg and his serum creatinine was 2.7 mg/dl.
In this patient who had a short proximal neck, we used an endograft with a proximal uncovered suprarenal stent. The covered part of the endograft was placed right below the renal artery and the proximal uncovered suprarenal stent was deployed in front of the renal artery.
Case 2
A 77-year-old man had high grade RAS of the left kidney, hypertension (22/110 mm Hg), serum creatinine of 1.98 mg/dl and infrarenal AAA (neck longer than 15 mm). This patient was treated with renal artery angioplasty and stenting. Blood pressure was improved (160/90 mm Hg) and antihypertensive medications were reduced, but his serum creatinine remained stable (1.96 mg/dl). After 8 months the AAA was treated by the placement of an infrarenal aortic endograft. In this patient there was sufficient neck length (Ͼ15 mm) and we used an infrarenal aortic endograft. Three months after endovascular repair of AAA, he continues to do well, his blood pressure was 140/80 mm Hg, but his renal function was slightly deteriorated (serum creatinine 2.37 mg/dl).
Case 3
A 73-year-old man had a 70% RAS of the left kidney, blood pressure 140/80 mm Hg, serum creatinine 1.2 mg/dl and infrarenal AAA with neck length less than 15 mm. This patient was simultaneously treated by placement of a renal artery stent and an aortic endograft with suprarenal stent.
Four months after intervention he continues to do well, his serum creatinine was 1.1 mg/dl and his blood pressure was 140/80 mm Hg.
All patients, according to pre-procedural planning, underwent a spiral CT scan and an angiogram with a marked catheter. The length of the proximal aortic neck was defined as the distance between the lowest renal artery and the proximal portion of the aneurysm.
Discussion
In this study, we describe three patients with coexisting RAS and abdominal aortic aneurysm. Several autopsy series emphasise the relationship between age and the presence of significant renal artery atherosclerosis. Increasing prevalence of RAS is found among elderly people. In cadaveric studies, the prevalence of serious RAS was 5% in patients younger than 64%, 18% in patients 65-74 years old and 42% in patients older than 74 years. [1] [2] [3] Several studies evaluated the prevalence of RAS in patients undergoing angiography for a variety of extrarenal problems including AAA, coronary artery disease, peripheral vascular disease and aortoocclusive disease. From angiographic data, the prevalence of RAS in patients with extrarenal vascular disease, ranges from 11% to 42%. The highest prevalence is among patients with peripheral vascular disease. In patients with AAA the prevalence of RAS is about 22%. If an infrarenal AAA is recognised in aortography, a high flush should be considered to examine the renal arteries. 1, 4 Percutaneous transluminal renal angioplasty is an accepted method of treatment of hypertension and renal dysfunction resulting from RAS. The role of renal artery stents in percutaneous revascularisation of the kidney is not yet clearly defined. However, available data suggest that renal artery stent placement is particularly helpful in ostial atheromatous lesions. Stent placement following percutaneous transluminal angioplasty (PTA) prevents immediate recoil, but does not exclude restenosis because the presence of an intra-arterial foreign body may be the cause for neointima formation. Nevertheless, percutaneous transluminal renal angioplasty may offer a favourable outcome in elderly high-risk patients with symptomatic RAS. The decision to perform angioplasty in RAS greater than 60% would appear reasonable as the occlusion may occur in 5% at 1 year and 11% at 2 years.
1,4-6
Before 1991, surgery was the treatment of choice for AAA. About a decade ago the endovascular treatment of AAA was first presented. Since then it has evolved as a technique for patients who are not candidates for open surgery. In high-risk patients with life-threatening AAA the aortic endografts represent the only treatment option. Therefore endovascular repair of AAA is a new and rapidly expanding technique. The procedure is technically successful and blood flow is excluded completely from the aneurysm sac. Initial reports emphasised the need for a sufficiently sized infrarenal neck for proper placement of the stent-graft. They suggest that the normal aorta between the orifices of the renal arteries and the beginning of AAA must have a length of at least 15 mm to ensure secure anchoring of the stent-graft. However, suprarenal placement of stent-grafts in some patients with infrarenal neck less than 15 mm (3-14 mm) was recently performed. No statistically significant differences in laboratory values and arterial blood pressure were found between patients with suprarenal and infrarenal placement of stent grafts. Renal function and perfusion remain unaffected in suprarenal placement of stent-grafts. [7] [8] [9] In our study there were two patients with AAA and unilateral RAS and one patient with AAA and solitary-functioning kidney with RAS.
Out of the three patients, one had hypertension and two had renal dysfunction. These patients were treated by placement of aortic endograft and renal artery angioplasty with or without stent placement (Figure 1) .
The two procedures were performed simultaneously in two patients without any adverse effect. Renal artery angioplasty and stenting can be performed at the same time with aortic endograft placement in the majority of patients, eliminating the need for a second procedure.
Aortic endografts are made out of a series of stents which are covered by a graft. Some of them have proximal uncovered stents which are deployed in front of the renal arteries. The covered stents are deployed below the renal arteries. In our patients we did not alter our usual technique of renal artery stent placement which includes that a short part of the stent should protrude for a few millimetres into the aorta.
During a short follow-up ranging from 3 to 8 months, renal function in two patients with renal dysfunction showed slight deterioration in one and improvement in the other (patient with solitary kidney), while it remained stable within normal values in the third patient. In one hypertensive patient blood pressure improved and medications were reduced and in the other two normotensive patients their blood pressure remained within normal limits. It is suggested by some reports that renal artery atherosclerotic disease is common even among normotensive patients, especially in elderly people. infrarenal deployment of aortic endografts. Recent reports include endografts with a proximal uncovered suprarenal stent. So far the presence of the suprarenal stent does not appear to impair kidney function. 2, 8 Complications of the endovascular repair of AAA include graft migration and endoleak. Probably improved graft design will secure longterm durability of this procedure. 9, 10 In conclusion, coexistence of RAS and AAA may be treated simultaneously by placement of an aortic endograft and renal artery angioplasty with or without stent. This combined treatment may prevent renal function deterioration and AAA rupture in elderly and high-risk patients.
